Advertisement

Heart and Vessels

, Volume 32, Issue 8, pp 909–915 | Cite as

Patients with Cheyne–Stokes respiration and heart failure: patient tolerance after three-month discontinuation of treatment with adaptive servo-ventilation

  • Arild Hetland
  • Tøri Vigeland Lerum
  • Kristina H. Haugaa
  • Thor Edvardsen
Original Article

Abstract

The recent SERVE HF study concluded that patients with chronic heart failure (CHF) and Cheyne–Stokes respiration (CSR) have increased mortality when treated with adaptive servo-ventilation (ASV). We, therefore, wanted to explore if these patients tolerated discontinuation of ASV treatment. The study was a prospective post-ASV treatment observational design with a 3-month follow-up period. 14 patients from our outpatient clinic, all male, were originally diagnosed with CHF and Cheyne–Stokes respiration, which is a clinical form of central sleep apnea. Left ventricular ejection fraction (LVEF) was ≤45% when ASV treatment was initiated. Median machine use was 68 (42–78) months when the patients were instructed to terminate ASV treatment. The patients were then followed during conventional CHF treatment for 3 months. Study baseline was set the last ASV treatment day. Sleep data were collected from the machine the last day of use. Apnea–hypopnea index (AHI), LVEF, 6-min walk test and 24-h ambulatory electrocardiogram recordings were performed at baseline and at study end. Life quality data were obtained using The Minnesota Living with Heart Failure Questionaire (MLHFQ). New York Heart Association Functional Classification (NYHA) was registered. An ambulatory sleep screening was performed at study end. AHI increased significantly after 3 months without ASV treatment [from 1.6 (0.8–3.2) to 39.2 (24.3–44.1, p = 0.001)]. Quality of life (QOL) decreased significantly: 30 (13–54) at discontinuation of ASV vs. 46 (24–67) (MLHFQ) at study end, p = 0.04. Though there was no significant change in NYHA functional class, patients especially reported increased shortness of breath, reduced concentration and reduced memory after discontinuation of ASV treatment. There were no significant differences in LVEF, heart rhythm data and physical capacity. Left ventricular function was preserved indicating that discontinuation of ASV in heart failure patients does not affect cardiac capacity. There was a significant decrement in QOL that must be considered in further treatment of these patients.

Keywords

Cheyne–Stokes respiration Chronic heart failure Adaptive servo-ventilation Left ventricular function 

Notes

Acknowledgements

This study was supported by The Hospital of Østfold, Fredrikstad, Norway.

Compliance with ethical standards

Conflict of interest

None.

Disclosures

None.

References

  1. 1.
    Jaffe LM, Kjekshus J, Gottlieb SS (2013) Importance and management of chronic sleep apnoea in cardiology. Eur Heart J 34(11):809–815CrossRefPubMedGoogle Scholar
  2. 2.
    Miyata M, Yoshihisa A, Yamauchi H, Owada T, Sato T, Suzuki S, Sugimoto K, Yamaki T, Kunii H, Nakazato K, Suzuki H, Saitoh S, Takeishi Y (2015) Impact of sleep-disordered breathing on myocardial damage and metabolism in patients with chronic heart failure. Heart Vessels 30(3):318–324CrossRefPubMedGoogle Scholar
  3. 3.
    Bitter T, Westerheide N, Prinz C, Hossain MS, Vogt J, Langer C, Horstkotte D, Oldenburg O (2011) Cheyne-stokes respiration and obstructive sleep apnoea are independent risk factors for malignant ventricular arrhythmias requiring appropriate cardioverter-defibrillator therapies in patients with congestive heart failure. Eur Heart J 32(1):61–74CrossRefPubMedGoogle Scholar
  4. 4.
    Wang Y, Cao J, Feng J, Chen BY (2015) Cheyne-stokes respiration during sleep: mechanisms and potential interventions. Br J Hosp Med (Lond) 76(7):390–396CrossRefGoogle Scholar
  5. 5.
    Sands SA, Owens R (2015) Congestive heart failure and central sleep apnea. Crit Care Clin 31(3):473–495CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Yumino D, Wang H, Floras JS, Newton GE, Mak S, Ruttanaumpawan P, Parker JD, Bradley TD (2009) Relationship between sleep apnoea and mortality in patients with ischaemic heart failure. Heart 95(10):819–824CrossRefPubMedGoogle Scholar
  7. 7.
    Bradley TD, Floras JS (2003) Sleep apnea and heart failure: part I: obstructive sleep apnea. Circulation 107(12):1671–1678CrossRefPubMedGoogle Scholar
  8. 8.
    Kasai T, Usui Y, Yoshioka T, Yanagisawa N, Takata Y, Narui K, Yamaguchi T, Yamashina A, Momomura S (2010) Effect of flow-triggered adaptive servo-ventilation compared with continuous positive airway pressure in patients with chronic heart failure with coexisting obstructive sleep apnea and Cheyne-Stokes respiration. Circ Heart Fail 3(1):140–148CrossRefPubMedGoogle Scholar
  9. 9.
    Oldenburg O, Lamp B, Faber L, Teschler H, Horstkotte D, Topfer V (2007) Sleep-disordered breathing in patients with symptomatic heart failure: a contemporary study of prevalence in and characteristics of 700 patients. Eur J Heart Fail 9(3):251–257CrossRefPubMedGoogle Scholar
  10. 10.
    Hanly PJ, Zuberi-Khokhar NS (1996) Increased mortality associated with Cheyne-Stokes respiration in patients with congestive heart failure. Am J Respir Crit Care Med 153(1):272–276CrossRefPubMedGoogle Scholar
  11. 11.
    Naughton MT (1998) Pathophysiology and treatment of Cheyne-stokes respiration. Thorax 53(6):514–518CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Bradley TD (2000) Continuous positive airway pressure for congestive heart failure. CMAJ 162(4):535–536PubMedPubMedCentralGoogle Scholar
  13. 13.
    Teschler H, Dohring J, Wang YM, Berthon-Jones M (2001) Adaptive pressure support servo-ventilation: a novel treatment for Cheyne-Stokes respiration in heart failure. Am J Respir Crit Care Med 164(4):614–619CrossRefPubMedGoogle Scholar
  14. 14.
    Bradley TD, Logan AG, Kimoff RJ, Series F, Morrison D, Ferguson K, Belenkie I, Pfeifer M, Fleetham J, Hanly P, Smilovitch M, Tomlinson G, Floras J (2005) Continuous positive airway pressure for central sleep apnea and heart failure. N Engl J Med 353(19):2025–2033CrossRefPubMedGoogle Scholar
  15. 15.
    Arzt M, Floras JS, Logan AG, Kimoff RJ, Series F, Morrison D, Ferguson K, Belenkie I, Pfifer M, Fleetham J, Hanly P, Smilovitch M, Ryan C, Tomlinson G, Bradley TD (2007) Suppression of central sleep apnea by continuous positive airway pressure and transplant-free survival in heart failure: a post hoc analysis of the canadian continuous positive airway pressure for patients with central sleep apnea and heart failure trial (CANPAP). Circulation 115(25):3173–3180CrossRefPubMedGoogle Scholar
  16. 16.
    Javaheri S, Brown LK, Randerath WJ (2014) Clinical applications of adaptive servoventilation devices: part 2. Chest 146(3):858–868CrossRefPubMedGoogle Scholar
  17. 17.
    Yoshihisa A, Suzuki S, Owada T, Iwaya S, Yamauchi H, Miyata M, Yamaki T, Sugimoto K, Kunii H, Nakazato K, Suzuki H, Saitoh S, Takeishi Y (2013) Short-term use of adaptive servo ventilation improves renal function in heart failure patients with sleep-disordered breathing. Heart Vessels 28(6):728–734CrossRefPubMedGoogle Scholar
  18. 18.
    Philippe C, Stoica-Herman M, Drouot X, Raffestin B, Escourrou P, Hittinger L, Michel PL, Roualt S, d’Ortho MP (2006) Compliance with and effectiveness of adaptive servoventilation versus continuous positive airway pressure in the treatment of Cheyne-Stokes respiration in heart failure over a six month period. Heart 92(3):337–342CrossRefPubMedGoogle Scholar
  19. 19.
    Tomita Y, Kasai T, Kisaka T, Rossiter HB, Kihara Y, Wasserman K, Daida H (2015) Altered breathing syndrome in heart failure: newer insights and treatment options. Curr Heart Fail Rep 12(2):158–165CrossRefPubMedGoogle Scholar
  20. 20.
    Cowie MR, Woehrle H, Wegscheider K, Angermann C, d’Ortho MP, Erdmann E, Levy P, Simonds A, Somers V, Zannad F, Teschler H (2015) Adaptive servo-ventilation for central sleep apnea in systolic heart failure. N Engl J Med 373(12):1095–1105CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Emdin M, Passino C, Giannoni A (2015) After the SERVE-HF trial, is there still a need for treatment of central apnea? J Card Fail 21(11):903–905CrossRefPubMedGoogle Scholar
  22. 22.
    Hetland A, Haugaa KH, Olseng M, Gjesdal O, Ross S, Saberniak J, Jacobsen M, Edvardsen T (2013) Three-month treatment with adaptive servoventilation improves cardiac function and physical activity in patients with chronic heart failure and cheyne-stokes respiration: a prospective randomized controlled trial. Cardiology 126(2):81–90CrossRefPubMedGoogle Scholar
  23. 23.
    Dingli K, Coleman EL, Vennelle M, Finch SP, Wraith PK, Mackay TW, Douglas NJ (2003) Evaluation of a portable device for diagnosing the sleep apnoea/hypopnoea syndrome. Eur Respir J 21(2):253–259CrossRefPubMedGoogle Scholar
  24. 24.
    Oldenburg O, Schmidt A, Lamp B, Bitter T, Muntean BG, Langer C, Horstkotte D (2008) Adaptive servoventilation improves cardiac function in patients with chronic heart failure and Cheyne-Stokes respiration. Eur J Heart Fail 10(6):581–586CrossRefPubMedGoogle Scholar
  25. 25.
    Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, Gutgesell H, Reichek N, Sahn D, Schnittger I, Silverman N, Tajik AJ (1989) Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American society of echocardiography committee on standards, subcommittee on quantitation of two-dimensional echocardiograms. J Am Soc Echocardiogr 2(5):358–367CrossRefPubMedGoogle Scholar
  26. 26.
    Nagueh SF, Smiseth OA, Appleton CP, Byrd III BF, Dokainish H, Edvardsen T, Flachskampf FA, Gillebert TC, Klein AL, Lancellotti P, Marino P, Oh JK, Popescu BA, Waggoner AD (2016) Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. doi: 10.1093/ehjci/jew082 PubMedGoogle Scholar
  27. 27.
    Enright PL (2003) The six-minute walk test. Respir Care 48(8):783–785PubMedGoogle Scholar
  28. 28.
    Carmona-Bernal C, Ruiz-Garcia A, Villa-Gil M, Sanchez-Armengol A, Quintana-Gallego E, Ortega-Ruiz F, Baron-Esquivias G, Capote F (2008) Quality of life in patients with congestive heart failure and central sleep apnea. Sleep Med 9(6):646–651CrossRefPubMedGoogle Scholar
  29. 29.
    Edvardsen T, Haugaa KH (2011) Imaging assessment of ventricular mechanics. Heart 97(16):1349–1356CrossRefPubMedGoogle Scholar
  30. 30.
    Haugaa KH, Smedsrud MK, Steen T, Kongsgaard E, Loennechen JP, Skjaerpe T, Voigt JU, Willems R, Smith G, Smiseth O, Amlie J, Edvardsen T (2010) Mechanical dispersion assessed by myocardial strain in patients after myocardial infarction for risk prediction of ventricular arrhythmia. JACC Cardiovasc Imaging 3(3):247–256CrossRefPubMedGoogle Scholar
  31. 31.
    Zhang XL, Yin KS, Li XL, Jia EZ, Su M (2006) Efficacy of adaptive servoventilation in patients with congestive heart failure and Cheyne-Stokes respiration. Chin Med J (Engl) 119(8):622–627Google Scholar
  32. 32.
    Hanly P, Zuberi-Khokhar N (1995) Daytime sleepiness in patients with congestive heart failure and Cheyne-Stokes respiration. Chest 107(4):952–958CrossRefPubMedGoogle Scholar
  33. 33.
    Lupon J, Gastelurrutia P, de Antonio M, Gonzalez B, Cano L, Cabanes R, Urrutia A, Diez C, Coll R, Altimir S, Bayes-Genis A (2013) Quality of life monitoring in ambulatory heart failure patients: temporal changes and prognostic value. Eur J Heart Fail 15(1):103–109CrossRefPubMedGoogle Scholar
  34. 34.
    Damy T, Margarit L, Noroc A, Bodez D, Guendouz S, Boyer L, Drouot X, Lamine A, Paulino A, Rappeneau S, Stoica MH, Dubois-Rande JL, Adnot S, Hittinger L, d’Ortho MP (2012) Prognostic impact of sleep-disordered breathing and its treatment with nocturnal ventilation for chronic heart failure. Eur J Heart Fail 14(9):1009–1019CrossRefPubMedGoogle Scholar
  35. 35.
    Pepperell JC, Maskell NA, Jones DR, Langford-Wiley BA, Crosthwaite N, Stradling JR, Davies J (2003) A randomized controlled trial of adaptive ventilation for Cheyne-Stokes breathing in heart failure. Am J Respir Crit Care Med 168(9):1109–1114CrossRefPubMedGoogle Scholar

Copyright information

© Springer Japan 2017

Authors and Affiliations

  • Arild Hetland
    • 1
    • 2
  • Tøri Vigeland Lerum
    • 1
  • Kristina H. Haugaa
    • 2
    • 3
  • Thor Edvardsen
    • 2
    • 3
  1. 1.The Hospital of ØstfoldFredrikstadNorway
  2. 2.Faculty of MedicineUniversity of OsloOsloNorway
  3. 3.Department of Cardiology and Center for Cardiological InnovationOslo University Hospital RikshospitaletOsloNorway

Personalised recommendations